Danaher's stock drop looks like a buying opportunity after it reported a solid quarter
We attribute Tuesday's 3% decline in DHR to management already preannouncing and shares making a large move into the print.
BigThink
0
22
In this photo illustration, Danaher Corporation logo seen displayed on a smartphone with the stock market information of Danaher Corporation in the background.
Igor Golovniov | Lightrocket | Getty Images
Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity.
